Interaction Energetics and Druggability of the Protein-Protein Interaction between Kelch-like ECH-Associated Protein 1 (KEAP1) and Nuclear Factor Erythroid 2 Like 2 (Nrf2)

Zhong, M; Lynch, A.; Muellers, S.; Jehle, S.; Luo, L.; Hall, D.; Iwase, R.; Carolan, J.; Egbert, M.; Wakefield, A.; Streu, K.; Harvey, C.; Ortet, P.; Kozakov, D.; Vajda, S.; Allen, K.; Whitty, A.

doi:10.1021/acs.biochem.9b00943

Interaction Energetics and Druggability of the Protein-Protein Interaction between Kelch-like ECH-Associated Protein 1 (KEAP1) and Nuclear Factor Erythroid 2 Like 2 (Nrf2)

Journal Article · 31 December 2021 · Biochemistry

DOI:https://doi.org/10.1021/acs.biochem.9b00943· OSTI ID:1808968

Zhong, M; Lynch, A.; Muellers, S.; Jehle, S.; Luo, L.; Hall, D.; Iwase, R.; Carolan, J.; Egbert, M.; Wakefield, A.; Streu, K.; Harvey, C.; Ortet, P.; Kozakov, D.; Vajda, S.; Allen, K.; Whitty, A.

Research Organization:: Brookhaven National Laboratory (BNL), Upton, NY (United States)

Sponsoring Organization:: ~OTHER

DOE Contract Number:: SC0012704

OSTI ID:: 1808968

Report Number(s):: BNL-221863-2021-JACI

Journal Information:: Biochemistry, Journal Name: Biochemistry Journal Issue: 4 Vol. 59; ISSN 0006-2960

Country of Publication:: United States

Language:: English

References (108)

Peptide inhibitors of the Keap1–Nrf2 protein–protein interaction Hancock, Rowena; Bertrand, Hélène C.; Tsujita, Tadayuki Free Radical Biology and Medicine, Vol. 52, Issue 2 https://doi.org/10.1016/j.freeradbiomed.2011.10.486	journal	January 2012
The Nrf2-Antioxidant Response Element Signaling Pathway and Its Activation by Oxidative Stress Nguyen, Truyen; Nioi, Paul; Pickett, Cecil B. Journal of Biological Chemistry, Vol. 284, Issue 20 https://doi.org/10.1074/jbc.R900010200	journal	May 2009
Multiple binding modes of a small molecule to human Keap1 revealed by X-ray crystallography and molecular dynamics simulation Satoh, Mikiya; Saburi, Hajime; Tanaka, Tomoyuki FEBS Open Bio, Vol. 5, Issue 1 https://doi.org/10.1016/j.fob.2015.06.011	journal	January 2015
Dimethyl Fumarate and Monoethyl Fumarate Exhibit Differential Effects on KEAP1, NRF2 Activation, and Glutathione Depletion In Vitro Brennan, Melanie S.; Matos, Maria F.; Li, Bing PLOS ONE, Vol. 10, Issue 3 https://doi.org/10.1371/journal.pone.0120254	journal	March 2015
Genetic Alteration of Keap1 Confers Constitutive Nrf2 Activation and Resistance to Chemotherapy in Gallbladder Cancer Shibata, Tatsuhiro; Kokubu, Akiko; Gotoh, Masahiro Gastroenterology, Vol. 135, Issue 4 https://doi.org/10.1053/j.gastro.2008.06.082	journal	October 2008
Reaching for high-hanging fruit in drug discovery at protein–protein interfaces Wells, James A.; McClendon, Christopher L. Nature, Vol. 450, Issue 7172 https://doi.org/10.1038/nature06526	journal	December 2007
Protein-protein docking benchmark version 4.0: Protein-Protein Docking Benchmark Version 4.0 Hwang, Howook; Vreven, Thom; Janin, Joël Proteins: Structure, Function, and Bioinformatics, Vol. 78, Issue 15 https://doi.org/10.1002/prot.22830	journal	July 2010
High-throughput assays for promiscuous inhibitors Feng, Brian Y.; Shelat, Anang; Doman, Thompson N. Nature Chemical Biology, Vol. 1, Issue 3 https://doi.org/10.1038/nchembio718	journal	July 2005
Fragment-based identification of druggable ‘hot spots’ of proteins using Fourier domain correlation techniques Brenke, Ryan; Kozakov, Dima; Chuang, Gwo-Yu Bioinformatics, Vol. 25, Issue 5 https://doi.org/10.1093/bioinformatics/btp036	journal	January 2009
Discovery of direct inhibitors of Keap1–Nrf2 protein–protein interaction as potential therapeutic and preventive agents Abed, Dhulfiqar Ali; Goldstein, Melanie; Albanyan, Haifa Acta Pharmaceutica Sinica B, Vol. 5, Issue 4 https://doi.org/10.1016/j.apsb.2015.05.008	journal	July 2015
Features and development of Coot Emsley, P.; Lohkamp, B.; Scott, W. G. Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 4 https://doi.org/10.1107/S0907444910007493	journal	March 2010
Relationship between Hot Spot Residues and Ligand Binding Hot Spots in Protein–Protein Interfaces Zerbe, Brandon S.; Hall, David R.; Vajda, Sandor Journal of Chemical Information and Modeling, Vol. 52, Issue 8 https://doi.org/10.1021/ci300175u	journal	July 2012
Dysfunctional KEAP1–NRF2 Interaction in Non-Small-Cell Lung Cancer Singh, Anju; Misra, Vikas; Thimmulappa, Rajesh K. PLoS Medicine, Vol. 3, Issue 10 https://doi.org/10.1371/journal.pmed.0030420	journal	October 2006
Evaluating the Catalytic Contribution from the Oxyanion Hole in Ketosteroid Isomerase Schwans, Jason P.; Sunden, Fanny; Gonzalez, Ana Journal of the American Chemical Society, Vol. 133, Issue 50 https://doi.org/10.1021/ja208050t	journal	December 2011
The Nrf2/ARE Pathway as a Potential Therapeutic Target in Neurodegenerative Disease Calkins, Marcus J.; Johnson, Delinda A.; Townsend, Jessica A. Antioxidants & Redox Signaling, Vol. 11, Issue 3 https://doi.org/10.1089/ars.2008.2242	journal	March 2009
Peptide segments in protein-protein interfaces Pal, Arumay; Chakrabarti, Pinak; Bahadur, Ranjit Journal of Biosciences, Vol. 32, Issue 1 https://doi.org/10.1007/s12038-007-0010-7	journal	January 2007
Targeting the Nrf2 pathway against cardiovascular disease Li, Jinqing; Ichikawa, Tomonaga; Janicki, Joseph S. Expert Opinion on Therapeutic Targets, Vol. 13, Issue 7 https://doi.org/10.1517/14728220903025762	journal	June 2009
A decade of fragment-based drug design: strategic advances and lessons learned Hajduk, Philip J.; Greer, Jonathan Nature Reviews Drug Discovery, Vol. 6, Issue 3 https://doi.org/10.1038/nrd2220	journal	February 2007
Hot-spot mimicry of a cytokine receptor by a small molecule Thanos, C. D.; DeLano, W. L.; Wells, J. A. Proceedings of the National Academy of Sciences, Vol. 103, Issue 42 https://doi.org/10.1073/pnas.0607058103	journal	October 2006
Emerging roles of Nrf2 and phase II antioxidant enzymes in neuroprotection Zhang, Meijuan; An, Chengrui; Gao, Yanqin Progress in Neurobiology, Vol. 100 https://doi.org/10.1016/j.pneurobio.2012.09.003	journal	January 2013
DRoP: A Water Analysis Program Identifies Ras-GTP-Specific Pathway of Communication between Membrane-Interacting Regions and the Active Site Kearney, Bradley M.; Johnson, Christian W.; Roberts, Daniel M. Journal of Molecular Biology, Vol. 426, Issue 3 https://doi.org/10.1016/j.jmb.2013.10.036	journal	February 2014
Between a rock and a hard place? Whitty, Adrian; Kumaravel, Gnanasambandam Nature Chemical Biology, Vol. 2, Issue 3 https://doi.org/10.1038/nchembio0306-112	journal	March 2006
Protection against electrophile and oxidant stress by induction of the phase 2 response: Fate of cysteines of the Keap1 sensor modified by inducers Wakabayashi, Nobunao; Dinkova-Kostova, Albena T.; Holtzclaw, W. David Proceedings of the National Academy of Sciences, Vol. 101, Issue 7 https://doi.org/10.1073/pnas.0307301101	journal	February 2004
The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1 Komatsu, Masaaki; Kurokawa, Hirofumi; Waguri, Satoshi Nature Cell Biology, Vol. 12, Issue 3 https://doi.org/10.1038/ncb2021	journal	February 2010
Optimization of Fluorescently Labeled Nrf2 Peptide Probes and the Development of a Fluorescence Polarization Assay for the Discovery of Inhibitors of Keap1-Nrf2 Interaction Inoyama, Daigo; Chen, Yu; Huang, Xinyi Journal of Biomolecular Screening, Vol. 17, Issue 4 https://doi.org/10.1177/1087057111430124	journal	December 2011
The FTMap family of web servers for determining and characterizing ligand-binding hot spots of proteins Kozakov, Dima; Grove, Laurie E.; Hall, David R. Nature Protocols, Vol. 10, Issue 5 https://doi.org/10.1038/nprot.2015.043	journal	April 2015
Focused grid‐based resampling for protein docking and mapping Mamonov, Artem B.; Moghadasi, Mohammad; Mirzaei, Hanieh Journal of Computational Chemistry, Vol. 37, Issue 11 https://doi.org/10.1002/jcc.24273	journal	February 2016
Crystal-contact engineering to obtain a crystal form of the Kelch domain of human Keap1 suitable for ligand-soaking experiments Hörer, Stefan; Reinert, Dirk; Ostmann, Katja Acta Crystallographica Section F Structural Biology and Crystallization Communications, Vol. 69, Issue 6 https://doi.org/10.1107/S174430911301124X	journal	May 2013
Phaser crystallographic software McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D. Journal of Applied Crystallography, Vol. 40, Issue 4 https://doi.org/10.1107/S0021889807021206	journal	July 2007
Keap1 Recruits Neh2 through Binding to ETGE and DLG Motifs: Characterization of the Two-Site Molecular Recognition Model Tong, Kit I.; Katoh, Yasutake; Kusunoki, Hideki Molecular and Cellular Biology, Vol. 26, Issue 8 https://doi.org/10.1128/MCB.26.8.2887-2900.2006	journal	April 2006
Structure–Activity and Structure–Property Relationship and Exploratory in Vivo Evaluation of the Nanomolar Keap1–Nrf2 Protein–Protein Interaction Inhibitor Jiang, Zheng-Yu; Xu, Li−Li; Lu, Meng-Chen Journal of Medicinal Chemistry, Vol. 58, Issue 16 https://doi.org/10.1021/acs.jmedchem.5b00185	journal	August 2015
Protein–protein interactions in human disease Ryan, D.; Matthews, J. Current Opinion in Structural Biology, Vol. 15, Issue 4 https://doi.org/10.1016/j.sbi.2005.06.001	journal	August 2005
Binding of Disordered Peptides to Kelch: Insights from Enhanced Sampling Simulations Do, Trang Nhu; Choy, Wing-Yiu; Karttunen, Mikko Journal of Chemical Theory and Computation, Vol. 12, Issue 1 https://doi.org/10.1021/acs.jctc.5b00868	journal	December 2015
A General Framework for Development and Data Analysis of Competitive High-Throughput Screens for Small-Molecule Inhibitors of Protein−Protein Interactions by Fluorescence Polarization ^† Roehrl, Michael H. A.; Wang, Julia Y.; Wagner, Gerhard Biochemistry, Vol. 43, Issue 51 https://doi.org/10.1021/bi048233g	journal	December 2004
High-resolution epitope mapping of hGH-receptor interactions by alanine-scanning mutagenesis Cunningham, B.; Wells, J. Science, Vol. 244, Issue 4908 https://doi.org/10.1126/science.2471267	journal	June 1989
A Comparative Assessment Study of Known Small-Molecule Keap1−Nrf2 Protein–Protein Interaction Inhibitors: Chemical Synthesis, Binding Properties, and Cellular Activity Tran, Kim T.; Pallesen, Jakob S.; Solbak, Sara M. Ø. Journal of Medicinal Chemistry, Vol. 62, Issue 17 https://doi.org/10.1021/acs.jmedchem.9b00723	journal	August 2019
Oxidative Stress Sensor Keap1 Functions as an Adaptor for Cul3-Based E3 Ligase To Regulate Proteasomal Degradation of Nrf2 Kobayashi, A.; Kang, M. -I.; Okawa, H. Molecular and Cellular Biology, Vol. 24, Issue 16 https://doi.org/10.1128/MCB.24.16.7130-7139.2004	journal	July 2004
Small molecules, big targets: drug discovery faces the protein–protein interaction challenge Scott, Duncan E.; Bayly, Andrew R.; Abell, Chris Nature Reviews Drug Discovery, Vol. 15, Issue 8 https://doi.org/10.1038/nrd.2016.29	journal	April 2016
KEAP1 E3 Ligase-Mediated Downregulation of NF-κB Signaling by Targeting IKKβ Lee, Dung-Fang; Kuo, Hsu-Ping; Liu, Mo Molecular Cell, Vol. 36, Issue 1 https://doi.org/10.1016/j.molcel.2009.07.025	journal	October 2009
Anatomy of hot spots in protein interfaces Bogan, Andrew A.; Thorn, Kurt S. Journal of Molecular Biology, Vol. 280, Issue 1 https://doi.org/10.1006/jmbi.1998.1843	journal	July 1998
FTMAP: extended protein mapping with user-selected probe molecules Ngan, C. H.; Bohnuud, T.; Mottarella, S. E. Nucleic Acids Research, Vol. 40, Issue W1 https://doi.org/10.1093/nar/gks441	journal	May 2012
Targeting protein–protein interactions for cancer therapy Fry, David C.; Vassilev, Lyubomir T. Journal of Molecular Medicine, Vol. 83, Issue 12 https://doi.org/10.1007/s00109-005-0705-x	journal	November 2005
High Levels of Nrf2 Determine Chemoresistance in Type II Endometrial Cancer Jiang, Tao; Chen, Ning; Zhao, Fei Cancer Research, Vol. 70, Issue 13 https://doi.org/10.1158/0008-5472.CAN-10-0713	journal	June 2010
Association of Keap1 and Nrf2 Genetic Mutations and Polymorphisms With Endometrioid Endometrial Adenocarcinoma Survival Wong, Tze Fang; Yoshinaga, Kousuke; Monma, Yasutake International Journal of Gynecological Cancer, Vol. 21, Issue 8 https://doi.org/10.1097/IGC.0b013e31822d0eb2	journal	January 2011
Ligand deconstruction: Why some fragment binding positions are conserved and others are not Kozakov, Dima; Hall, David R.; Jehle, Stefan Proceedings of the National Academy of Sciences, Vol. 112, Issue 20 https://doi.org/10.1073/pnas.1501567112	journal	April 2015
Program DYNAFIT for the Analysis of Enzyme Kinetic Data: Application to HIV Proteinase Kuzmič, Petr Analytical Biochemistry, Vol. 237, Issue 2 https://doi.org/10.1006/abio.1996.0238	journal	June 1996
ANCHOR: a web server and database for analysis of protein-protein interaction binding pockets for drug discovery Meireles, L. M. C.; Domling, A. S.; Camacho, C. J. Nucleic Acids Research, Vol. 38, Issue Web Server https://doi.org/10.1093/nar/gkq502	journal	June 2010
The emerging role of the Nrf2-Keap1 signaling pathway in cancer Jaramillo, M. C.; Zhang, D. D. Genes & Development, Vol. 27, Issue 20 https://doi.org/10.1101/gad.225680.113	journal	October 2013
Hot spots in protein–protein interfaces: Towards drug discovery Cukuroglu, Engin; Engin, H. Billur; Gursoy, Attila Progress in Biophysics and Molecular Biology, Vol. 116, Issue 2-3 https://doi.org/10.1016/j.pbiomolbio.2014.06.003	journal	November 2014
Structural conservation of druggable hot spots in protein-protein interfaces Kozakov, D.; Hall, D. R.; Chuang, G. -Y. Proceedings of the National Academy of Sciences, Vol. 108, Issue 33 https://doi.org/10.1073/pnas.1101835108	journal	August 2011
Molecular mechanisms of the Keap1-Nrf2 pathway in stress response and cancer evolution: Molecular mechanisms of the Keap1-Nrf2 pathway Taguchi, Keiko; Motohashi, Hozumi; Yamamoto, Masayuki Genes to Cells, Vol. 16, Issue 2 https://doi.org/10.1111/j.1365-2443.2010.01473.x	journal	January 2011
The atomic structure of protein-protein recognition sites 1 1Edited by A. R. Fersht Conte, Loredana Lo; Chothia, Cyrus; Janin, Joël Journal of Molecular Biology, Vol. 285, Issue 5 https://doi.org/10.1006/jmbi.1998.2439	journal	February 1999
Comprehensive Experimental and Computational Analysis of Binding Energy Hot Spots at the NF-κB Essential Modulator/IKKβ Protein–Protein Interface Golden, Mary S.; Cote, Shaun M.; Sayeg, Marianna Journal of the American Chemical Society, Vol. 135, Issue 16 https://doi.org/10.1021/ja400914z	journal	April 2013
Structural and biochemical characterization of the KLHL3–WNK kinase interaction important in blood pressure regulation Schumacher, Frances-Rose; Sorrell, Fiona J.; Alessi, Dario R. Biochemical Journal, Vol. 460, Issue 2 https://doi.org/10.1042/BJ20140153	journal	May 2014
Druggability Indices for Protein Targets Derived from NMR-Based Screening Data Hajduk, Philip J.; Huth, Jeffrey R.; Fesik, Stephen W. Journal of Medicinal Chemistry, Vol. 48, Issue 7 https://doi.org/10.1021/jm049131r	journal	April 2005
Fumarates Promote Cytoprotection of Central Nervous System Cells against Oxidative Stress via the Nuclear Factor (Erythroid-Derived 2)-Like 2 Pathway Scannevin, Robert H.; Chollate, Sowmya; Jung, Mi-young Journal of Pharmacology and Experimental Therapeutics, Vol. 341, Issue 1 https://doi.org/10.1124/jpet.111.190132	journal	January 2012
Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2 Wang, X. -J.; Sun, Z.; Villeneuve, N. F. Carcinogenesis, Vol. 29, Issue 6 https://doi.org/10.1093/carcin/bgn095	journal	April 2008
Permeability of lipid bilayers to water and ionic solutes Deamer, David W.; Bramhall, John Chemistry and Physics of Lipids, Vol. 40, Issue 2-4 https://doi.org/10.1016/0009-3084(86)90069-1	journal	June 1986
Crystal Structure of the Kelch Domain of Human Keap1 Li, Xuchu; Zhang, Donna; Hannink, Mark Journal of Biological Chemistry, Vol. 279, Issue 52 https://doi.org/10.1074/jbc.M410073200	journal	December 2004
PGAM5 tethers a ternary complex containing Keap1 and Nrf2 to mitochondria Lo, Shih-Ching; Hannink, Mark Experimental Cell Research, Vol. 314, Issue 8 https://doi.org/10.1016/j.yexcr.2008.02.014	journal	May 2008
Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction Yung-Chi, Cheng; Prusoff, William H. Biochemical Pharmacology, Vol. 22, Issue 23 https://doi.org/10.1016/0006-2952(73)90196-2	journal	December 1973
Predicting protein interaction sites: binding hot-spots in protein–protein and protein–ligand interfaces Burgoyne, Nicholas J.; Jackson, Richard M. Bioinformatics, Vol. 22, Issue 11 https://doi.org/10.1093/bioinformatics/btl079	journal	March 2006
Unraveling hot spots in binding interfaces: progress and challenges DeLano, Warren L. Current Opinion in Structural Biology, Vol. 12, Issue 1 https://doi.org/10.1016/S0959-440X(02)00283-X	journal	February 2002
Binding Mode and Structure-Activity Relationships around Direct Inhibitors of the Nrf2-Keap1 Complex Jnoff, Eric; Albrecht, Claudia; Barker, John J. ChemMedChem, Vol. 9, Issue 4 https://doi.org/10.1002/cmdc.201300525	journal	February 2014
Targeting protein–protein interactions as an anticancer strategy Ivanov, Andrei A.; Khuri, Fadlo R.; Fu, Haian Trends in Pharmacological Sciences, Vol. 34, Issue 7 https://doi.org/10.1016/j.tips.2013.04.007	journal	July 2013
Small-Molecule Inhibitors of Protein-Protein Interactions: Progressing toward the Reality Arkin, Michelle R.; Tang, Yinyan; Wells, James A. Chemistry & Biology, Vol. 21, Issue 9 https://doi.org/10.1016/j.chembiol.2014.09.001	journal	September 2014
The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer Kansanen, Emilia; Kuosmanen, Suvi M.; Leinonen, Hanna Redox Biology, Vol. 1, Issue 1 https://doi.org/10.1016/j.redox.2012.10.001	journal	January 2013
Interpreting Steep Dose-Response Curves in Early Inhibitor Discovery Shoichet, Brian K. Journal of Medicinal Chemistry, Vol. 49, Issue 25 https://doi.org/10.1021/jm061103g	journal	December 2006
Structural analysis of the complex of Keap1 with a prothymosin α peptide Padmanabhan, Balasundaram; Nakamura, Yoshihiro; Yokoyama, Shigeyuki Acta Crystallographica Section F Structural Biology and Crystallization Communications, Vol. 64, Issue 4 https://doi.org/10.1107/S1744309108004995	journal	March 2008
Hot Spot Analysis for Driving the Development of Hits into Leads in Fragment-Based Drug Discovery Hall, David R.; Ngan, Chi Ho; Zerbe, Brandon S. Journal of Chemical Information and Modeling, Vol. 52, Issue 1 https://doi.org/10.1021/ci200468p	journal	December 2011
Discovery and Development of Kelch-like ECH-Associated Protein 1. Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein–Protein Interaction Inhibitors: Achievements, Challenges, and Future Directions Jiang, Zheng-Yu; Lu, Meng-Chen; You, Qi-Dong Journal of Medicinal Chemistry, Vol. 59, Issue 24 https://doi.org/10.1021/acs.jmedchem.6b00586	journal	October 2016
Protein-protein interaction inhibitors: advances in anticancer drug design Ferreira, Leonardo G.; Oliva, Glaucius; Andricopulo, Adriano D. Expert Opinion on Drug Discovery, Vol. 11, Issue 10 https://doi.org/10.1080/17460441.2016.1223038	journal	August 2016
Modified Peptide Inhibitors of the Keap1–Nrf2 Protein–Protein Interaction Incorporating Unnatural Amino Acids Georgakopoulos, Nikolaos D.; Talapatra, Sandeep K.; Gatliff, Jemma ChemBioChem, Vol. 19, Issue 17 https://doi.org/10.1002/cbic.201800170	journal	July 2018
Exploring the structural origins of cryptic sites on proteins Beglov, Dmitri; Hall, David R.; Wakefield, Amanda E. Proceedings of the National Academy of Sciences, Vol. 115, Issue 15 https://doi.org/10.1073/pnas.1711490115	journal	March 2018
The rise of fragment-based drug discovery Murray, Christopher W.; Rees, David C. Nature Chemistry, Vol. 1, Issue 3 https://doi.org/10.1038/nchem.217	journal	June 2009
Analysis of Binding Site Hot Spots on the Surface of Ras GTPase Buhrman, Greg; O′Connor, Casey; Zerbe, Brandon Journal of Molecular Biology, Vol. 413, Issue 4 https://doi.org/10.1016/j.jmb.2011.09.011	journal	November 2011
Structure–Activity and Structure–Conformation Relationships of Aryl Propionic Acid Inhibitors of the Kelch-like ECH-Associated Protein 1/Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1/NRF2) Protein–Protein Interaction Heightman, Tom D.; Callahan, James F.; Chiarparin, Elisabetta Journal of Medicinal Chemistry, Vol. 62, Issue 9 https://doi.org/10.1021/acs.jmedchem.9b00279	journal	April 2019
Keap1 Is a Redox-Regulated Substrate Adaptor Protein for a Cul3-Dependent Ubiquitin Ligase Complex Zhang, Donna D.; Lo, Shih-Ching; Cross, Janet V. Molecular and Cellular Biology, Vol. 24, Issue 24 https://doi.org/10.1128/MCB.24.24.10941-10953.2004	journal	December 2004
Molecular effects of cancer-associated somatic mutations on the structural and target recognition properties of Keap1 Khan, Halema; Killoran, Ryan C.; Brickenden, Anne Biochemical Journal, Vol. 467, Issue 1 https://doi.org/10.1042/BJ20140761	journal	March 2015
A detergent-based assay for the detection of promiscuous inhibitors Feng, Brian Y.; Shoichet, Brian K. Nature Protocols, Vol. 1, Issue 2 https://doi.org/10.1038/nprot.2006.77	journal	June 2006
New Frontiers in Druggability Kozakov, Dima; Hall, David R.; Napoleon, Raeanne L. Journal of Medicinal Chemistry, Vol. 58, Issue 23 https://doi.org/10.1021/acs.jmedchem.5b00586	journal	August 2015
Lessons from Hot Spot Analysis for Fragment-Based Drug Discovery Hall, David R.; Kozakov, Dima; Whitty, Adrian Trends in Pharmacological Sciences, Vol. 36, Issue 11 https://doi.org/10.1016/j.tips.2015.08.003	journal	November 2015
An Nrf2/Small Maf Heterodimer Mediates the Induction of Phase II Detoxifying Enzyme Genes through Antioxidant Response Elements Itoh, Ken; Chiba, Tomoki; Takahashi, Satoru Biochemical and Biophysical Research Communications, Vol. 236, Issue 2 https://doi.org/10.1006/bbrc.1997.6943	journal	July 1997
Monoacidic Inhibitors of the Kelch-like ECH-Associated Protein 1: Nuclear Factor Erythroid 2-Related Factor 2 (KEAP1:NRF2) Protein–Protein Interaction with High Cell Potency Identified by Fragment-Based Discovery Davies, Thomas G.; Wixted, William E.; Coyle, Joseph E. Journal of Medicinal Chemistry, Vol. 59, Issue 8 https://doi.org/10.1021/acs.jmedchem.6b00228	journal	April 2016
A hot spot of binding energy in a hormone-receptor interface Clackson, T.; Wells, J. Science, Vol. 267, Issue 5196 https://doi.org/10.1126/science.7529940	journal	January 1995
Nrf2 protects against airway disorders Cho, Hye-Youn; Kleeberger, Steven R. Toxicology and Applied Pharmacology, Vol. 244, Issue 1 https://doi.org/10.1016/j.taap.2009.07.024	journal	April 2010
Molecular Properties That Influence the Oral Bioavailability of Drug Candidates Veber, Daniel F.; Johnson, Stephen R.; Cheng, Hung-Yuan Journal of Medicinal Chemistry, Vol. 45, Issue 12 https://doi.org/10.1021/jm020017n	journal	June 2002
Phosphorylation of p62 Activates the Keap1-Nrf2 Pathway during Selective Autophagy Ichimura, Yoshinobu; Waguri, Satoshi; Sou, Yu-shin Molecular Cell, Vol. 51, Issue 5 https://doi.org/10.1016/j.molcel.2013.08.003	journal	September 2013
Structure of the Keap1:Nrf2 interface provides mechanistic insight into Nrf2 signaling Lo, Shih-Ching; Li, Xuchu; Henzl, Michael T. The EMBO Journal, Vol. 25, Issue 15 https://doi.org/10.1038/sj.emboj.7601243	journal	August 2006
Detection of secondary binding sites in proteins using fragment screening Ludlow, R. Frederick; Verdonk, Marcel L.; Saini, Harpreet K. Proceedings of the National Academy of Sciences, Vol. 112, Issue 52 https://doi.org/10.1073/pnas.1518946112	journal	December 2015
Superstar: improved knowledge-based interaction fields for protein binding sites11Edited by R. Huber Verdonk, Marcel L.; Cole, Jason C.; Watson, Paul Journal of Molecular Biology, Vol. 307, Issue 3 https://doi.org/10.1006/jmbi.2001.4452	journal	March 2001
Small molecules inhibit the interaction of Nrf2 and the Keap1 Kelch domain through a non-covalent mechanism Marcotte, Douglas; Zeng, Weike; Hus, Jean-Christophe Bioorganic & Medicinal Chemistry, Vol. 21, Issue 14 https://doi.org/10.1016/j.bmc.2013.04.019	journal	July 2013
Kinetic Analyses of Keap1-Nrf2 Interaction and Determination of the Minimal Nrf2 Peptide Sequence Required for Keap1 Binding Using Surface Plasmon Resonance: Kinetic Analyses of Keap1-Nrf2 Peptide Interactions Chen, Yu; Inoyama, Daigo; Kong, Ah-Ng Tony Chemical Biology & Drug Design, Vol. 78, Issue 6 https://doi.org/10.1111/j.1747-0285.2011.01240.x	journal	October 2011
Small Molecule Modulators of Keap1-Nrf2-ARE Pathway as Potential Preventive and Therapeutic Agents: SMALL MOLECULE MODULATORS OF KEAP1-NRF2-ARE PATHWAY Magesh, Sadagopan; Chen, Yu; Hu, Longqin Medicinal Research Reviews, Vol. 32, Issue 4 https://doi.org/10.1002/med.21257	journal	May 2012
Nrf2 and Keap1 Abnormalities in Non–Small Cell Lung Carcinoma and Association with Clinicopathologic Features Solis, Luisa M.; Behrens, Carmen; Dong, Wenli Clinical Cancer Research, Vol. 16, Issue 14 https://doi.org/10.1158/1078-0432.CCR-09-3352	journal	June 2010
A systematic molecular dynamics approach to the study of peptide Keap1–Nrf2 protein–protein interaction inhibitors and its application to p62 peptides Lu, Meng-Chen; Yuan, Zhen-Wei; Jiang, Yong-Lin Molecular BioSystems, Vol. 12, Issue 4 https://doi.org/10.1039/C6MB00030D	journal	January 2016
Twenty years on: the impact of fragments on drug discovery Erlanson, Daniel A.; Fesik, Stephen W.; Hubbard, Roderick E. Nature Reviews Drug Discovery, Vol. 15, Issue 9 https://doi.org/10.1038/nrd.2016.109	journal	July 2016
Different Electrostatic Potentials Define ETGE and DLG Motifs as Hinge and Latch in Oxidative Stress Response Tong, Kit I.; Padmanabhan, Balasundaram; Kobayashi, Akira Molecular and Cellular Biology, Vol. 27, Issue 21 https://doi.org/10.1128/MCB.00753-07	journal	November 2007
A ‘Rule of Three’ for fragment-based lead discovery? Congreve, Miles; Carr, Robin; Murray, Chris Drug Discovery Today, Vol. 8, Issue 19 https://doi.org/10.1016/S1359-6446(03)02831-9	journal	October 2003
An Experimental Approach to Mapping the Binding Surfaces of Crystalline Proteins Allen, Karen N.; Bellamacina, Cornelia R.; Ding, Xiaochun The Journal of Physical Chemistry, Vol. 100, Issue 7 https://doi.org/10.1021/jp952516o	journal	January 1996
Hot spots-A review of the protein-protein interface determinant amino-acid residues Moreira, Irina S.; Fernandes, Pedro A.; Ramos, Maria J. Proteins: Structure, Function, and Bioinformatics, Vol. 68, Issue 4 https://doi.org/10.1002/prot.21396	journal	June 2007
Predicting druggable binding sites at the protein–protein interface Fuller, Jonathan C.; Burgoyne, Nicholas J.; Jackson, Richard M. Drug Discovery Today, Vol. 14, Issue 3-4 https://doi.org/10.1016/j.drudis.2008.10.009	journal	February 2009
Probing the structural requirements of non-electrophilic naphthalene-based Nrf2 activators Jain, Atul D.; Potteti, Haranatha; Richardson, Benjamin G. European Journal of Medicinal Chemistry, Vol. 103 https://doi.org/10.1016/j.ejmech.2015.08.049	journal	October 2015
Protein-protein interaction modulators: advances, successes and remaining challenges Mabonga, Lloyd; Kappo, Abidemi Paul Biophysical Reviews, Vol. 11, Issue 4 https://doi.org/10.1007/s12551-019-00570-x	journal	July 2019
Oncogenic NRF2 mutations in squamous cell carcinomas of oesophagus and skin: NRF2 in squamous cell carcinomas Kim, Yoo Ri; Oh, Ji Eun; Kim, Min Sung The Journal of Pathology, Vol. 220, Issue 4 https://doi.org/10.1002/path.2653	journal	October 2009
Inhibitors of protein–protein interactions (PPIs): an analysis of scaffold choices and buried surface area Ran, Xu; Gestwicki, Jason E. Current Opinion in Chemical Biology, Vol. 44 https://doi.org/10.1016/j.cbpa.2018.06.004	journal	June 2018
Inhibiting Protein-Protein Interactions as an Emerging Paradigm for Drug Discovery Gerrard, J.; Hutton, C.; Perugini, M. Mini-Reviews in Medicinal Chemistry, Vol. 7, Issue 2 https://doi.org/10.2174/138955707779802561	journal	February 2007
Binding of disordered proteins to a protein hub Cino, Elio A.; Killoran, Ryan C.; Karttunen, Mikko Scientific Reports, Vol. 3, Issue 1 https://doi.org/10.1038/srep02305	journal	July 2013

Similar Records

Interaction Energetics and Druggability of the Protein–Protein Interaction between Kelch-like ECH-Associated Protein 1 (KEAP1) and Nuclear Factor Erythroid 2 Like 2 (Nrf2)

Journal Article · 2019 · Biochemistry · OSTI ID:1599418

Isoquinoline Kelch-like ECH-Associated Protein 1-Nuclear Factor (Erythroid-Derived 2)-like 2 (KEAP1-NRF2) Inhibitors with High Metabolic Stability

Journal Article · 2020 · J. Med. Chem. · OSTI ID:1635686

Discovery of a Kelch-like ECH-associated protein 1-inhibitory tetrapeptide and its structural characterization

Journal Article · 2017 · Biochemical and Biophysical Research Communications · OSTI ID:22697000

Related Subjects

99 GENERAL AND MISCELLANEOUS

Interaction Energetics and Druggability of the Protein-Protein Interaction between Kelch-like ECH-Associated Protein 1 (KEAP1) and Nuclear Factor Erythroid 2 Like 2 (Nrf2)

Citation Formats

References (108)

Similar Records

Related Subjects